var data={"title":"Lactulose: Pediatric drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Lactulose: Pediatric drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/6431?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=lactulose-drug-information\" class=\"drug drug_general\">see &quot;Lactulose: Drug information&quot;</a> and <a href=\"topic.htm?path=lactulose-patient-drug-information\" class=\"drug drug_patient\">see &quot;Lactulose: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186541\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Constulose;</li>\n      <li>Enulose;</li>\n      <li>Generlac;</li>\n      <li>Kristalose</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186542\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Apo-Lactulose;</li>\n      <li>Jamp-Lactulose;</li>\n      <li>Pharma-Lactulose;</li>\n      <li>PMS-Lactulose;</li>\n      <li>Teva-Lactulose</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059636\" class=\"list_set htclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Therapeutic Category</span>\n    <ul>\n      <li>\n        <span class=\"list-set-name\">Ammonium Detoxicant</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Hyperammonemia Agent</span>;</li>\n      <li>\n        <span class=\"list-set-name\">Laxative, Miscellaneous</span></li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059630\" class=\"block dos drugH1Div\"><span class=\"drugH1\">Dosing: Usual</span><p>(For additional information <a href=\"topic.htm?path=lactulose-drug-information\" class=\"drug drug_general\">see &quot;Lactulose: Drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Pediatric:  <b>Note:</b>  Doses in pediatric patients may be expressed in volume (mL) or weight (g); use extra precaution.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Constipation; chronic:</b> Limited data available: Infants, Children, and Adolescents:  Oral:  1 to 2 g/kg/day (1.5 to 3 mL/kg/day) divided once or twice daily (NASPGHAN [Tabbers 2014]); maximum daily dose: 60 mL/day in adults</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Constipation, palliative care:</b>  Limited data available:  Children and Adolescents: Oral: 2 to 30 mL every 6 to 24 hours (Johnston 2005), others have suggested 5 to 10 mL every 2 hours until bowel movement (Kliegman 2011)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Fecal impaction, slow disimpaction:</b>  Limited data available: Infants, Children, and Adolescents:  Oral: 1.33 g/kg/dose (2 mL/kg) twice daily for 7 days (Wyllie 2011; Pashankar 2005)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Portal systemic encephalopathy, prevention:</b> Oral liquid:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Infants: 1.7 to 6.7 g/day (2.5 to 10 mL/day) in divided doses; adjust dosage to produce 2 to 3 stools/day </p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children and Adolescents: 26.7 to 60 g/day (40 to 90 mL/day) in divided doses; adjust dosage to produce 2 to 3 stools/day </p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Adult:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Constipation:</b> Oral: 10 to 20 g (15 to 30 mL) daily; may increase to 40 g (60 mL) daily if necessary</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Portal systemic encephalopathy, prevention:</b> Oral: 20 to 30 g (30 to 45 mL) 3 to 4 times/day; adjust dose every 1 to 2 days to produce 2 to 3 soft stools/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <b>Portal systemic encephalopathy, treatment:</b></p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Oral: 20 to 30 g (30 to 45 mL) every 1 hour to induce rapid laxation; reduce to 20 to 30 g (30 to 45 mL) 3 to 4 times/day after laxation is achieved; titrate to produce 2 to 3 soft stools/day</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Rectal administration (retention enema): 200 g (300 mL) diluted with 700 mL of water or NS via rectal balloon catheter; retain for 30 to 60 minutes; may repeat every 4 to 6 hours; transition to oral treatment prior to discontinuing rectal administration</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in renal impairment:</b> There are no dosage adjustments provided in manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dosing adjustment in hepatic impairment:</b>  There are no dosage adjustments provided in manufacturer's labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186523\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Packet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Kristalose: 10 g (30 ea); 20 g (30 ea)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Constulose: 10 g/15 mL (237 mL, 946 mL) [unflavored flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Enulose: 10 g/15 mL (473 mL) [unflavored flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generlac: 10 g/15 mL (473 mL, 1892 mL) [unflavored flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 10 g/15 mL (15 mL, 30 mL, 236 mL, 237 mL, 473 mL, 480 mL, 500 mL [DSC], 946 mL, 1892 mL); 20 g/30 mL (30 mL)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186508\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Availability (US)</span>\n    <p style=\"text-indent:0em;display:inline\">May be product dependent</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059639\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Oral:  </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Oral solution: May mix with fruit juice, water, or milk</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Crystals for oral solution: Dissolve contents of packet in 120 mL water</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Rectal: Adults: Mix with water or normal saline; administer as retention enema using a rectal balloon catheter; retain for 30 to 60 minutes. Transition to oral lactulose when appropriate (able to take oral medication and no longer a risk for aspiration) prior to discontinuing rectal administration.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186538\" class=\"block sts drugH1Div\"><span class=\"drugH1\">Storage/Stability</span>\n    <p style=\"text-indent:0em;display:inline\">Store at room temperature; do not freeze. Protect from light. Discard solution if cloudy or very dark. Prolonged exposure to cold temperatures will cause thickening which will return to normal upon warming to room temperature.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059638\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Prevention and treatment of portal-systemic encephalopathy (PSE) (Enulose: FDA approved in infants, children, adolescents, and adults); treatment of constipation (FDA approved in adults)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186591\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Lactulose may be confused with lactose</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186589\" class=\"block arm drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Endocrine &amp; metabolic: Dehydration, hypernatremia, hypokalemia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Abdominal cramps, abdominal distention, abdominal distress, diarrhea (excessive dose), eructation, flatulence, nausea, vomiting</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186530\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;display:inline\">Patients requiring a low galactose diet</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186512\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Electrolyte imbalance: Monitor periodically for electrolyte imbalance when lactulose is used &gt;6 months or in patients predisposed to electrolyte abnormalities (eg, elderly, debilitated patients). Hepatic disease may predispose patients to electrolyte imbalance. Infants receiving lactulose may develop hyponatremia and dehydration.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Diabetes: Use with caution in patients with diabetes mellitus; solution contains galactose and lactose.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Electrocautery procedures: During proctoscopy or colonoscopy procedures involving electrocautery, a theoretical risk of reaction between H<sub>2</sub> gas accumulation and electrical spark may exist; thorough bowel cleansing with a nonfermentable solution is recommended.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F26021850\" class=\"block add-pediatric-warn-info drugH1Div\"><span class=\"drugH1\">Warnings: Additional Pediatric Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Electrolyte imbalances may occur with chronic use or in patients predisposed to electrolyte imbalances including infants; infants may also develop dehydration with hyponatremia.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13299571\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186517\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=13405&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Glutamine: May diminish the therapeutic effect of Lactulose. Specifically, glutamine may diminish the ammonia-lowering effects of lactulose.<i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186519\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">B (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13763432\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Adverse events have not been observed in animal reproduction studies. Lactulose is poorly absorbed following oral administration. Use of dietary fiber or bulk-forming laxatives along with increased fluid intake is generally considered first line therapy for treating constipation in pregnant women. Short-term use of lactulose is also considered to be safe/low risk when therapy is needed; however, side effects may limit its use (Cullen, 2007; Mahadevan, 2006; Prather, 2004; Wald, 2003).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059635\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Serum ammonia, serum electrolytes, fluid status, stool output </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186511\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">The bacterial degradation of lactulose resulting in an acidic pH inhibits the diffusion of NH<sub>3</sub> into the blood by causing the conversion of NH<sub>3</sub> to NH<sub>4</sub>+; also enhances the diffusion of NH<sub>3</sub> from the blood into the gut where conversion to NH<sub>4</sub>+ occurs; produces an osmotic effect in the colon with resultant distention promoting peristalsis; reduces blood ammonia concentration to reduce the degree of portal systemic encephalopathy</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186529\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics (Adult data unless noted)</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Onset:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Constipation: Up to 24 to 48 hours to produce a normal bowel movement</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Encephalopathy: At least 24 to 48 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Absorption: Poor</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Metabolism: Via colonic flora to lactic acid and acetic acid; requires colonic flora for drug activation</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Excretion: Primarily feces; urine (&le;3%)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F1059643\" class=\"block adi drugH1Div\"><span class=\"drugH1\">Additional Information</span>\n    <p style=\"text-indent:0em;display:inline\">Upon discontinuation of therapy, allow 24 to 48 hours for resumption of normal bowel movements</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186532\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Pack</b> (Kristalose Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10 g (30): $253.29</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">20 g (30): $262.48</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Lactulose Encephalopathy Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10 g/15 mL (473 mL): $36.50</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Lactulose Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10 g/15 mL (30 mL): $0.81</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F186534\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Actilax (AU);</li>\n      <li>Alvolaxus (TH);</li>\n      <li>Amivalex (HU);</li>\n      <li>Bifiteral (BE, DE, LU);</li>\n      <li>Biolac (PH);</li>\n      <li>Comfort (BD);</li>\n      <li>Danilax (HK);</li>\n      <li>Dhactulose (HK, MY, SG);</li>\n      <li>Dia-Colon (IT);</li>\n      <li>Dismam L (PE);</li>\n      <li>Dufalak (UA);</li>\n      <li>Duphalac (AE, AT, AU, BE, BG, BH, CL, CN, CY, CZ, EC, EE, EG, ES, FI, FR, GB, GR, HK, HR, HU, ID, IE, IQ, IR, IT, JO, KR, KW, LB, LK, LT, LU, LV, LY, MT, MY, NL, NO, NZ, OM, PE, PH, PK, PL, PT, PY, QA, RO, RU, SA, SE, SG, SK, SY, TH, TR, TW, VN, YE, ZA);</li>\n      <li>Extralac (ID);</li>\n      <li>Ezilax (BH, JO, KW, QA);</li>\n      <li>Farlac (BR);</li>\n      <li>Genlac (AU);</li>\n      <li>Genocolan (AR);</li>\n      <li>Hepalac (TH);</li>\n      <li>Lac-Dol (AU);</li>\n      <li>Lacoly (TW);</li>\n      <li>Lacson (ZA);</li>\n      <li>Lactocur (AU, LU);</li>\n      <li>Lactu (BD);</li>\n      <li>Lactul (MY, TW);</li>\n      <li>Lactulax (EC, ID, MX, UY);</li>\n      <li>Lactulen (CO);</li>\n      <li>Lactulon (PY);</li>\n      <li>Lactulosa (EC);</li>\n      <li>Lactulose-ratiopharm (LU);</li>\n      <li>Lactumed (MY);</li>\n      <li>Lactus (SG);</li>\n      <li>Lactuverlan (DE);</li>\n      <li>Laevolac (AT, CN, HK, IE, IL, IT, NZ, PT, TH, VN);</li>\n      <li>Laktuvit (UA);</li>\n      <li>Laxadilac (ID);</li>\n      <li>Laxal (PE);</li>\n      <li>Laxalan (CR, DO, GT, HN, NI, PA, PE, SV);</li>\n      <li>Laxette (ZA);</li>\n      <li>Laxiright (LK);</li>\n      <li>Laxol (LK);</li>\n      <li>Laxolac (ET, LK);</li>\n      <li>Laxose (IE);</li>\n      <li>Legendal (CH);</li>\n      <li>Levolac (FI, NO);</li>\n      <li>Lidong (CN);</li>\n      <li>Lilac (PH);</li>\n      <li>Lipebin (AE, BH, CY, EG, IL, IQ, IR, JO, KW, LB, LY, OM, PE, QA, SA, SY, YE);</li>\n      <li>Livo Luk (IN);</li>\n      <li>Livoluk (TZ);</li>\n      <li>Losalac (TH);</li>\n      <li>Medilax (DK, IS);</li>\n      <li>Medulak (UA);</li>\n      <li>Moderan (VE);</li>\n      <li>Monilac (JP);</li>\n      <li>Movelax (PH);</li>\n      <li>Nophalac (MY);</li>\n      <li>Normase (IL, MT);</li>\n      <li>Normolax (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Opilax (ID);</li>\n      <li>Portalak (HR, UA);</li>\n      <li>Pralax (ID);</li>\n      <li>Ramlac (LB);</li>\n      <li>Regulact (MX);</li>\n      <li>Rialac (AE, BH, JO, KW, QA);</li>\n      <li>Rilax (PH);</li>\n      <li>Sarex (TH);</li>\n      <li>Soflax (AE, QA, SA);</li>\n      <li>Sorbilac (HK, LK);</li>\n      <li>Tenualax (AR);</li>\n      <li>Ticolax (LK);</li>\n      <li>Tulos (BD);</li>\n      <li>Tulotract (DE);</li>\n      <li>Veelac (BD)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Constulose solution (lactulose) [prescribing information]. Morristown, NJ: Actavis Inc; January 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Enulose solution (lactulose) [prescribing information]. Morristown, NJ: Actavis Inc; January 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kristalose powder for solution (lactulose) [prescribing information]. Nashville, TN: Cumberland Pharmaceuticals Inc: </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Cullen G, O'Donoghue D. Constipation and pregnancy. <i>Best Pract Res Clin Gastroenterol</i>. 2007;21(5):807-818.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lactulose-pediatric-drug-information/abstract-text/17889809/pubmed\" target=\"_blank\" id=\"17889809\">17889809</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. <i>Gastroenterology</i>. 2006;131(1):283-311.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lactulose-pediatric-drug-information/abstract-text/16831611/pubmed\" target=\"_blank\" id=\"16831611\">16831611</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Pashankar DS. Childhood constipation: evaluation and management.<i> Clin Colon Rectal Surg</i>. 2005;18(2):120-127.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lactulose-pediatric-drug-information/abstract-text/20011352 /pubmed\" target=\"_blank\" id=\"20011352 \">20011352 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Prather CM. Pregnancy-related constipation. <i>Curr Gastroenterol Rep</i>. 2004;6(5):402-404.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lactulose-pediatric-drug-information/abstract-text/15341717/pubmed\" target=\"_blank\" id=\"15341717\">15341717</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. <i>J Pediatr Gastroenterol Nutr</i>. 2014;58(2):258-274.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lactulose-pediatric-drug-information/abstract-text/24345831 /pubmed\" target=\"_blank\" id=\"24345831 \">24345831 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wald A. Constipation, diarrhea, and symptomatic hemorrhoids during pregnancy. <i>Gastroenterol Clin North Am</i>. 2003;32(1):309-322.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/lactulose-pediatric-drug-information/abstract-text/12635420/pubmed\" target=\"_blank\" id=\"12635420\">12635420</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wyllie R, Hyams JS, eds. <i>Pediatric Gastrointestinal and Liver Disease: Expert Consult - Online and Print</i>. 4th ed. Philadelphia, PA: Saunders; January 2011.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 13405 Version 135.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F186541\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F186542\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Therapeutic Category\" href=\"#F1059636\" class=\"outlineLink\">Therapeutic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Usual\" href=\"#F1059630\" class=\"outlineLink\">Dosing: Usual</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F186523\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Availability (US)\" href=\"#F186508\" class=\"outlineLink\">Generic Availability (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F1059639\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Storage/Stability\" href=\"#F186538\" class=\"outlineLink\">Storage/Stability</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F1059638\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F186591\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F186589\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F186530\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F186512\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Warnings: Additional Pediatric Considerations\" href=\"#F26021850\" class=\"outlineLink\">Warnings: Additional Pediatric Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13299571\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F186517\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F186519\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F13763432\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F1059635\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F186511\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics (Adult data unless noted)\" href=\"#F186529\" class=\"outlineLink\">Pharmacodynamics/Kinetics (Adult data unless noted)</a></li><li class=\"plainItem\"><a sectionName=\"Additional Information\" href=\"#F1059643\" class=\"outlineLink\">Additional Information</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F186532\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F186534\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_PED/13405|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=lactulose-drug-information\" class=\"drug drug_general\">Lactulose: Drug information</a></li><li><a href=\"topic.htm?path=lactulose-patient-drug-information\" class=\"drug drug_patient\">Lactulose: Patient drug information</a></li></ul></div></div>","javascript":null}